Literature DB >> 25674205

The role of RIP1 and RIP3 in the development of aplastic anemia induced by cyclophosphamide and busulphan in mice.

Yong-Feng Chen1, Zhi-Qiang Zhao1, Zhong-Min Wu2, Zhen-You Zou2, Xin-Jing Luo2, Jing Li3, Cong Xie4, Yong Liang5.   

Abstract

This study aimed to investigate the role of RIP1 and RIP3 in the pathogenesis of aplastic anemia (AA) induced by cyclophosphamide and busulphan in mice. Animals were randomly divided into three groups: the control group, the AA group, and the Nec-1 group. Mouse AA model was established by intraperitoneal injection of cyclophosphamide (40 mg/kg/d) and busulfan (20 mg/kg/d) for 12 days. The Nec-1 group mice received intraperitoneal injection of Nec-1 (2 mg/kg/d) for 12 days prior to intraperitoneal injection of cyclophosphamide (40 mg/kg/d) and busulfan (20 mg/kg/d) for 12 days. The control mice received intraperitoneal injection of equal volume of saline. At 12 h after the last intraperitoneal injection, blood and bone marrow tissues were collected from mice. Peripheral blood cells were analyzed using hematology analyzer and the histological changes of bone marrow tissues were examined using scanning electron microscopy (SEM). The levels of RIP3 and RIP3 in bone marrow were measured using Western blot analysis and the interaction of RIP1 and RIP3 proteins was investigated on the basis of immunoprecipitation analysis. ELISA was used to measure the levels of IL-6, TNF-α, and FLT-3L in bone marrow tissue supernatant. Apoptosis and necrosis of bone marrow cells were analyzed using flow cytometry. Western blot showed that the expression of RIP1 and RIP3 was significantly increases in AA mice compared to the normal controls. Immunoprecipitation detected the pro-necrotic RIP1-RIP3 complex, suggesting that RIP1 and RIP3 mediated necroptosis may involved in the damage of bone marrow cells. Compared to the AA mice, Nec-1 group mice exhibited significantly increase of peripheral blood cells and mononuclear cells in bone marrow tissues and decrease of the apoptosis/necrosis of bone marrow cells. In addition, we observed significant decrease of IL-6, TNF-α, and FLT-3L in bone marrow tissue supernatant in the Nec-1 group mice compared to AA mice. Our results suggest that Nec-1 can prevent the development of AA by inhibiting bone marrow cells necrosis and the production of inflammatory mediators. RIP1 and RIP3-mediated necroptosis may involve in the pathogenesis of AA induced by cyclophosphamide and busulfan in mice.

Entities:  

Keywords:  RIP1; RIP3; aplastic anemia; bone marrow cells; mouse; necroptosis

Mesh:

Substances:

Year:  2014        PMID: 25674205      PMCID: PMC4314042     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  30 in total

Review 1.  Cell death: critical control points.

Authors:  Nika N Danial; Stanley J Korsmeyer
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation.

Authors:  Marion C Bonnet; Daniela Preukschat; Patrick-Simon Welz; Geert van Loo; Maria A Ermolaeva; Wilhelm Bloch; Ingo Haase; Manolis Pasparakis
Journal:  Immunity       Date:  2011-10-13       Impact factor: 31.745

Review 3.  Cell death modalities: classification and pathophysiological implications.

Authors:  L Galluzzi; M C Maiuri; I Vitale; H Zischka; M Castedo; L Zitvogel; G Kroemer
Journal:  Cell Death Differ       Date:  2007-04-13       Impact factor: 15.828

4.  Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia/reperfusion injury.

Authors:  Xingshun Xu; Kao-Wei Chua; Chu C Chua; Chun-Feng Liu; Ronald C Hamdy; Balvin H L Chua
Journal:  Brain Res       Date:  2010-08-01       Impact factor: 3.252

Review 5.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.

Authors:  Michael T Lin; M Flint Beal
Journal:  Nature       Date:  2006-10-19       Impact factor: 49.962

6.  Necrostatin: a potentially novel cardioprotective agent?

Authors:  Christopher C T Smith; Sean M Davidson; Shiang Y Lim; James C Simpkin; John S Hothersall; Derek M Yellon
Journal:  Cardiovasc Drugs Ther       Date:  2007-07-31       Impact factor: 3.727

7.  Excessive production of tumor necrosis factor-alpha by bone marrow T lymphocytes is essential in causing bone marrow failure in patients with aplastic anemia.

Authors:  Takeshi Hara; Kazuki Ando; Hisashi Tsurumi; Hisataka Moriwaki
Journal:  Eur J Haematol       Date:  2004-07       Impact factor: 2.997

8.  Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

Authors:  Young Sik Cho; Sreerupa Challa; David Moquin; Ryan Genga; Tathagat Dutta Ray; Melissa Guildford; Francis Ka-Ming Chan
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

9.  Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis.

Authors:  Claudia Günther; Eva Martini; Nadine Wittkopf; Kerstin Amann; Benno Weigmann; Helmut Neumann; Maximilian J Waldner; Stephen M Hedrick; Stefan Tenzer; Markus F Neurath; Christoph Becker
Journal:  Nature       Date:  2011-09-14       Impact factor: 49.962

10.  Expression level of IL-6 secreted by bone marrow stromal cells in mice with aplastic anemia.

Authors:  Yong Feng Chen; Zhong Min Wu; Cong Xie; Shi Bai; Li Dong Zhao
Journal:  ISRN Hematol       Date:  2013-06-18
View more
  4 in total

1.  Deregulation of vital mitotic kinase-phosphatase signaling in hematopoietic stem/progenitor compartment leads to cellular catastrophe in experimental aplastic anemia.

Authors:  Ritam Chatterjee; Sukalpa Chattopadhyay; Sujata Law
Journal:  Mol Cell Biochem       Date:  2016-09-08       Impact factor: 3.396

2.  Gadofullerene nanoparticles for robust treatment of aplastic anemia induced by chemotherapy drugs.

Authors:  Wang Jia; Mingming Zhen; Lei Li; Chen Zhou; Zihao Sun; Shuai Liu; Zhongpu Zhao; Jie Li; Chunru Wang; Chunli Bai
Journal:  Theranostics       Date:  2020-05-23       Impact factor: 11.556

Review 3.  Redox Control in Acute Lymphoblastic Leukemia: From Physiology to Pathology and Therapeutic Opportunities.

Authors:  Yongfeng Chen; Jing Li; Zhiqiang Zhao
Journal:  Cells       Date:  2021-05-17       Impact factor: 6.600

Review 4.  Immunological consequences of kidney cell death.

Authors:  Maysa Sarhan; Anne von Mässenhausen; Christian Hugo; Rainer Oberbauer; Andreas Linkermann
Journal:  Cell Death Dis       Date:  2018-01-25       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.